An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial

Condition:   COVID-19 Interventions:   Drug: Hydroxychloroquine;   Drug: Lopinavir / Ritonavir;   Drug: Interferon Beta-1A;   Drug: Interferon Beta-1B Sponsor:   Shahid Beheshti University of Medical Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials